Dengue is one of the most widespread vector-borne viral diseases in the world. However, the size, 48
INTRODUCTION
reaction [16] . Although 5' capture technology does not theoretically afford the same transcript coverage 138 as other techniques, the total transcript recovery and unique gene recovery rate per cell is comparable 139 with other technologies, and the exponentially greater number of cells analyzed allows for an 140 unparalleled level of population resolution [16, 23] . Therefore, given the theoretical advantages offered 141 by a 5' capture approach, we attempted to determine if the technology is compatible with cell-associated 142
DENV detection and quantification in the presence or absence of a virus-specific cDNA synthesis 143 primer. 144 145
In this study, we first analyzed cells infected in vitro with DENV-1 utilizing 5' capture scRNAseq. 146
Despite the absence of a canonical polyadenylated tail, DENV RNA was incorporated in the 5' capture 147 scRNAseq reactions containing only an oligo(dT) primer, as well as in reactions supplemented with a 148
DENV-specific primer. The addition of a DENV-specific cDNA synthesis primer did not appreciably 149 increase either the total amount of DENV RNA captured by 5'capture scRNAseq analysis or the fraction 150 of cells flagged as containing DENV RNA. The only effect observed upon the addition of a DENV-151 specific primer was an increase in the viral genome coverage proximal to the primer binding site. The 152 majority of the DENV sequences recovered aligned to the 5' end of the viral genome, but a regular 153 pattern of higher-density coverage was noted across all in vitro infection samples. We then verified that 154 5' capture scRNAseq can be utilized to detect/quantify cell-associated DENV RNA in PBMC from an 155
individual experiencing a natural secondary DENV-1 infection. To test the feasibility of quantifying intracellular DENV RNA in a 5' capture scRNAseq assay -and the 167 necessity for a DENV-specific primer in the RT reactionwe first utilized an in vitro cell infection 168 model (Figure 1A) . A DC-SIGN (CD209) expressing CEM.NK R cell line (NKR2001A) was infected 169
with DENV-1 (strain Nauru/West Pac/1974) at a MOI of 1 and cultured for 18 hours prior to harvest and 170 analysis. Surface DENV-1 NS1 expression was assessed to confirm productive infection, and NS1 pos 171 cells were sorted from the DENV-1 infected culture (Figure 1B) . The uninfected parental 172 CEM.NK R .DC-SIGN cell line, the bulk-DENV1 infected culture, and the sorted DENV-1 infected 173 NS1 pos population were all subjected to scRNAseq 5' capture analysis using a standard oligo(dT) RT 174 primer for cDNA synthesis (Supplemental Figure 1) . In addition, a parallel scRNAseq 5' capture assay 175 was performed on the sorted DENV1 infected NS1 pos population where a DENV-specific primer was 176 added in addition to the conventional oligo(dT) primer at a 1:100 ratio (Supplemental Figure 1) . 177
Illumina-compatible NGS libraries were then generated from all samples, and sequenced to an 178 equivalent depth on a NovaSeq6000 instrument with a 2x150bp paired-end (PE) read configuration. 179
Samples were subsequently demultiplexed and aligned against the human GRCh38 or DENV-1(NCBI 180
Reference Sequence NC_001477.1) reference genomes.
182
An equivalent number of PE reads from all samples were confidently aligned and annotated against the 183 human GRCh38 reference genome, indicating that neither DENV-1 infection nor the addition of the 184 DENV-specific primer to the cDNA synthesis reaction significantly impacted the read depth/quality of 185 the host genome-derived RNA sequence data ( Figure 1C , Table 1 ). In contrast, the number of PE reads 186 confidently mapped against the DENV-1 reference genome varied significantly between the uninfected 187 and DENV-infected samples, with the least number of reads identified in the uninfected samples (334 of 188 7.2x10 8 total PE reads), and the most in the sorted NS1 pos DENV1 infected sample (1.9x10 6 of 9.6x10 8 189 total PE reads). The number of reads confidently mapped to the DENV-1 reference genome was 190 additionally reflected in the fraction of captured cells flagged as containing >=1 transcript of DENV 191
RNA (Figure 1D) . No cells from the uninfected cell culture dataset were flagged as containing DENV 192
RNA, while ~70% of the cells from the bulk DENV infected culture were identified as harboring DENV 193
RNA. Furthermore, more than 98% of the cells in both of the sorted NS1 pos DENV-1 infected samples 194
were identified as containing DENV-1 RNA. These data demonstrate that DENV RNA can be detected 195
using 5' capture scRNAseq analysis, and that a DENV-specific primer is not necessary to obtain this 196 result. 197 198 Quantification of DENV RNA by 5' capture scRNAseq 199 200
To better characterize the DENV RNA identified in our scRNAseq 5' capture assay, we examined the 201 abundance and length of each unique RNA template tagged with a unique molecular identifier (UMI) 202 that mapped to the DENV1 reference genome. The number of unique UMI-tagged DENV RNA 203 molecules identified (DENV RNA-positive) per cell ranged between 1 and 500 in all infected samples, 204
with the sorted NS1 pos populations containing on average 2X the number of DENV-1 mapped UMIs as 205 the unsorted DENV1 infected sample (Figure 2A) . No significant increase in the number of UMIs/cell 206 was observed within the sample containing the additional DENV specific primer. The length of the 207
DENV-1 reads ranged between 100 and 600bp, which is consistent with the library preparation strategy 208 utilized during the assay (Figure 2B) . Correspondingly, on average each DENV-mapped UMI reflected 209 ~3% of the DENV-1 genome (Figure 2C) . When aligned in aggregate, the total DENV genome 210 recovered per cell ranged between 3% and 99%, with the median genome recovery rate significantly 211 higher in the sorted NS1 pos DENV infected samples than in the bulk-infected sample ( Figure 2D) . On 212 average, 50% full-length DENV-1 genome coverage was achieved with 38.3 UMIs per cell across all 213 infected samples, while 75% genome coverage was achieved with 100 UMIs per cell (Figure 2E ). 214
Therefore, despite a single UMI providing a relatively small fragment of the DENV genome, a full-215 length cell-associated consensus genome can be constructed from relatively few unique transcripts. 216 217
Genomic coverage of positive-sense DENV generated by 5' capture scRNAseq 218 219
Many cells captured in this analysis contained DENV RNA that confidently mapped across a significant 220 fraction of the DENV-1 genome. Therefore, we attempted to ascertain whether there were regions of 221 preferential sequence recovery in our analysis or if the recovery was uniform across the DENV genome. 222
We additionally attempted to determine if the inclusion of a DENV-specific RT primer altered the 223 distribution of DENV genomic sequence recovery.
225
Consistent with the 5' capture technology utilized in this analysis, ~27.5% to 32.0 of all positive-sense 226
DENV-1 reads aligned to the first 500bp of the DENV genome in each sample (Figure 3A, 3B, 3C) . 227
However, a consistent pattern of enriched positive-sense genomic sequence recovery was noted in all 228 samples within the 3' end of the polyprotein encoding region of the DENV genome ( Figure 3A, 3B , 229 3C). Inclusion of the DENV-specific primer increased the genomic coverage 300-500bp upstream of 230 the primer binding site in (Figure 3C) . 231 232
Detection of negative-sense DENV RNA by 5' capture scRNAseq 233 234
Productive DENV infection is accompanied by the generation of intracellular negative-sense DENV 235
RNA [24] . As with other members of the virus family Flaviviridae, this intermediate antigenome is 236 utilized as a template for the synthesis of additional positive-sense DENV genomic RNA [25] . In our 237 analysis we observed that 67% of the unenriched DENV-1 infected CM.NK R cells analyzed by 238 oligo(dT) primed scRNAseq simultaneously contained reads that mapped to either the positive-or 239
negative-sense orientation of the DENV genome (herein referred to as positive-or negative-sense 240 DENV RNA, respectively) ( Figure 4A) . In contrast, 99% of sorted NS1 pos cellswhich by definition 241
are productively infectedcontained both positive-and negative-sense DENV RNA (Figure 4A) . 242
Within DENV-infected cells, negative-sense DENV RNA accounted for ~7.1% of all annotated DENV 243
RNA in both unfractionated and sorted NS1 pos DENV-1 infected cells ( Figure 4B) . A linear relationship 244
was observed between the amount of positive-sense DENV RNA identified within a cell and the 245 corresponding abundance of negative-sense RNA (Figure 4C) . However, the relatively low r 2 value of 246 these relationships (DENV-1 infected: 0.37. Sorted NS1 pos DENV-1 infected: 0.25) suggests that factors 247
other than the abundance of positive-sense DENV contributes to the relative abundance of negative-248 sense DENV RNA within DENV infected cells. 249 250
Enriched regions of negative-sense DENV RNA recovery was observed across the DENV genome in 251 samples analyzed by 5' capture scRNAseq ( Figure 4D) . However, the pattern of negative-sense DENV 252
RNA recovery is distinct from that observed for positive-sense DENV RNA in the same samples. These 253 results demonstrate that 5' capture scRNAseq can identify negative-sense DENV RNA within DENV 254
infected cells, and that the frequency of cells harboring negative-sense DENV RNA corresponds with 255 the presumed frequency of productive DENV infection.
257
Detection of DENV RNA in PBMC following natural infection by 5' capture scRNAseq 258 259
To determine the feasibility of identifying and quantifying PBMC harboring DENV RNA following 260 natural viral infection using 5' capture scRNAseq, we analyzed PBMC samples obtained from an 261
individual experiencing a natural secondary DENV1 infection. To maximize the accuracy and sensitivity 262 of the 5' capture scRNAseq dependent detection of DENV genomic RNA, a custom DENV-1 reference 263 was created using the sequence of the serum-associated virus infecting the individual in this study 264 (Supplemental Figure 3 , Table 2 ). NGS analysis of the serum-associated DENV reservoir captured in 265 this analysis provided a full-length genome with a coverage depth of 1000x or greater from both time 266 points assessed in this study (fever day -2, fever day -1) ( Table 2) . A 20% variant level analysis showed 267 no genomic sequence variants at either time point within the serum-associated viral reservoir. However, 268 a 1% variant level analysis showed 4 called synonymous variants at position 445 and 9565 in the DENV 269
polyprotein coding region that were present in equal frequencies at both time points ( Table 2) .
271
Two sequential PBMC samples were analyzed from this individual during the acute stage of infection 272
(fever day -2, fever day -1), as well as a 'baseline' sample from 180 days post defervescence. Total 273 viable CD3 + T cells and CD19 + B cells were sorted from the cryopreserved sample and analyzed by 5' 274 capture scRNAseq using an oligo(dT) primer for cDNA synthesis. A total of 9,565 cells were captured 275 across all 3 time points, and 11 transcriptionally distinct cell populations annotated using cell-associated 276 transcripts confidently aligned against the GRCh38 reference genome (Figure 5A , Supplemental  277 Figure 4, Supplemental Table 1 ). Cell-associated transcripts not mapped to the GrCh38 reference 278 genome were subsequently aligned against a custom DENV-1 reference generated from the sequence of 279 the serum-associated virus identified by targeted NGS sequencing (Supplemental Figure 3 , Table 2 ). 280
Consistent with previously published reports, DENV-1 transcripts were identified within the peripheral 281 B cell compartment in both naïve and memory-phenotype B cells (Figure 5B, 5C ). Both positive-and 282
negative-sense DENV RNA was identified within the cells, indicating that they were productively 283 infected (Supplemental Figure 5) . Although the total amount of DENV RNA recovered in this assay 284
was insufficient to provide a full-length genome in any individual cell (Figure 5D, 5E ), in aggregate 285
there was enough cell-associated DENV genomic material to generate a consensus genome sequence 286
across both acute infection time points (Figure 5F , Table 2 ). 287 288
Consistent with the coverage results obtained from the in vitro infection experiments, the majority of the 289 confidently mapped DENV-1 reads came from the first 500bp of the DENV-1 genome (Day -2: 50.73%. 290
Day -1: 53.3%). Although the cell-associated DENV genome sequencing depth was limited in this 291 analysis, the synonymous genomic variants observed at position 445 within the serum-associated viral 292
reservoir were also observed within the cell-associated viral reservoir at a nearly identical frequency at 293
both time points analyzed ( Table 2 ). In addition, a further 16 variants at 8 genomic positions were 294 observed within the cell-associated viral reservoir that were not observed within the contemporaneous 295 serum-associated viral reservoirs ( Table 2) . While the intracellular DENV sequence depth is limited in 296 this analysis, these results suggest a greater degree of genomic variation within the cell-associated 297
DENV viral reservoir during acute DENV infection than in the serum-associated viral reservoir. 298 299 300 DISCUSSION 301
In this study we demonstrate that DENV genomic RNA can be captured and quantified by 5' capture 302
scRNAseq. Despite the absence of a conventional polyadenylated 3' tail, DENV genomic RNA was 303 successfully captured utilizing an oligo(dT) primer without addition of a DENV-specific RT primer. The 304
addition of a DENV-specific primer during the cDNA synthesis step did not appreciably increase the 305 number of DENV RNA molecules captured by 5' scRNAseq analysis. The majority of the DENV 306 sequences recovered in this analysis aligned to the 5' end of the viral genome, but a regular pattern of 307 higher-density coverage was noted across all in vitro infection samples as well. As sequence recovery 308 corresponds to locations where cDNA synthesis terminates in 5' capture scRNAseq, this pattern may 309 reflect unappreciated secondary structures in the native intracellular DENV genome that impeded the 310 reverse transcriptase processivity. We additionally verified that 5' capture scRNAseq can be utilized to 311 detect/quantify physiologically-relevant levels of cell-associated DENV RNA by analyzing samples 312 from an individual experiencing a natural secondary DENV-1 infection. This analysis recapitulated 313 previous reports by detecting virally infected B cells, and, in addition, we were able to compare the 314 sequence of the cell-associated and serum virus in the same individual. While both cell-associated and 315 serum viruses possessed an identical intra-host single-nucleotide variant (iSNV) with approximately 316 equal frequencies in one of the genomic positions, additional iSNVs were observed within the cell-317 associated viral reservoir that were not observed within the contemporaneous serum. While it is well 318 known that DENV exists as a population of viral variants within a host, here for the first time we show 319 that these viral populations are similar, though not identical, in composition and frequency within these 320 two different host compartments. Virus population compartmentalization has been well described in 321
HIV [26] , and has been associated with disease severity. Whereas the chronic nature of HIV infection is 322
in stark contrast to DENV, more studies are needed to determine if population compartmentalization and 323 heterogeneity has any relationship to dengue severity. 324 325
The observation that DENV genomic RNA is captured in a reverse transcription reaction utilizing 326
anchored-oligo(dT) priming was initially unexpected but is not without precedent. Previous studies have 327 demonstrated that cDNA can be generated from flavivirus genomic RNA templates using an oligo(dT) 328
primer, although the exact oligo(dT) primer binding sites were not resolved [27] . Furthermore, the 329 anchored-oligo(dT) primer used in this analysis contains a degenerate 3' terminus, which may increase 330 the likelihood of the oligo binding/priming off a sequence other than a canonical mRNA poly-A tail. 331
Indeed, internal transcript priming at A rich regions is a long-appreciated problem with oligo(dT) based 332
RT-methods [28] [29] [30] [31] [32] . However, while it is plausibleeven probable -that the oligo(dT) primer used in 333 the analysis presented here bound to polypyrimidine tracts within the DENV genome, the exact location 334 of these internal priming events cannot be determined using this approach. This is due to the fact that the 335 5' capture assay used in this study preferentially captures sequences from regions of RT-termination, 336
rather than RT-initiation [16, 23] . 337 338
While the location of RT initiation cannot be resolved by 5' scRNAseq, this approach may unexpectedly 339 allow for the resolution of native secondary/tertiary structures within the intracellular DENV genome. 340
Extensive secondary structures within an RNA template can severely impede the processivity of a 341 reverse transcriptase, leading to the production of truncated cDNA molecules downstream of the initial 342
priming event [33, 34] . This inherent feature of RT-dependent cDNA synthesis may be exacerbated by 343
the fact that the MMLV-derived RT used in this 5' capture assay displays maximal enzymatic activity at 344 43 o C: a temperature at which significant secondary structures will be retained in single-stranded RNA 345
templates. The observation that the inclusion of a DENV-specific RT primer only increases the depth of 346 the recovered DENV genome at 200-500bp downstream of the primer binding site reinforces the 347 concept that RT processivity overall is profoundly limited on the DENV genome in the described 348 scRNAseq assay. Therefore, if RT processivity is indeed limited on the DENV genome in this assay, 349 oligo(dT) priming must occur frequently in order to achieve the levels of full genome coverage observed 350 in our analysis. Approximately 2000-8000 cells per reaction suspended at a density of 50-500 cells/μL in PBS plus 405 0.5% FBS were loaded for gel bead-in-emulsion (GEM) generation and barcoding. Reverse 406 transcription, RT-cleanup, and cDNA amplification were performed to isolate and amplify cDNA for 407 downstream 5′ gene or enriched V(D)J library construction according to the manufacturer's protocol. 408
Libraries were constructed using the Chromium Single-Cell 5′ reagent kit, 5′ Library Construction Kit, 409
and i7 Multiplex Kit (10x Genomics, CA) according to the manufacturer's protocol.
411
Sequencing: scRNAseq 5′ gene expression libraries were sequenced on an Illumina NovaSeq 6000 412 instrument using the S1, S2, or S4 reagent kits (300 cycles Transcript alignment was performed against a custom DENV-1 reference library generated using the 436
Cell Ranger mkref command and the DENV-1 (strain Westpac74) FASTA and the corresponding gene 437 GTF, or a custom DENV-1 FASTA generated from targeted NGS analysis of contemporaneous serum 438 samples from the individual analyzed in the study. 439 440
Cell associated DENV UMI dependent genomic visualization: DENV-1 mapped reads were provided 441 in BAM format from the Cell Ranger pipeline. UMI-tools dedup was used to deduplicate the BAM files 442 on a per cell basis using cell barcode, UMI barcode, and alignment position of the paired end reads [51] .
443
BAM files were split into positive-sense and negative-sense mapped reads using BAM alignment tags 444 provided by the Cellranger pipeline. Only read pairs where both reads mapped to the same genomic 445 orientation were utilized in downstream visualizations. Using a list of cell barcodes identified as being 446
associated with an intact cell by the cellranger count analysis of GRCh38 aligned transcripts, cell and 447 unique UMI specific statistics were extracted using an in-house pipeline. In short, the BAM files were 448 subset by cell barcode using 10x Genomics subset-bam followed conversion to fastq using bedtools 449
bamToFastq [52] . The reads were then remapped using BWA-MEM and the BWA produced BAM files 450
were analyzed using a custom Python script with a samtools [53] depth frontend. Unique UMI codes 451
were extracted from the subset cell BAM and used to further subset the individual cell BAMs. The 452
unique UMI assemblies were then analyzed similarly for assembly and coverage statistics. DENV-1 453 (strain Westpac74) was used as a reference for the in vitro samples and the constructed serum consensus 454
was used for the natural infection samples.
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